Dr.. Suzette Delaloge is a medical oncologist and researcher at the Department of Medical Oncology, Gustave Roussy. She is a specialist in breast cancer and cancer prevention, holds a Doctor of Medicine (MD) and a Master of Science (MSc) degree, and trained in France and Canada. She led the Breast Cancer Group at Gustave Roussy from 2004 to 2021 and has been Director of the personalized prevention program “Interception” since 2021. Her areas of expertise include risk-based precision cancer prevention, precision oncology in breast cancer, real-world data, and oncology care organization. She currently chairs or has chaired numerous national and European scientific initiatives, including the European MyPeBS project, dedicated to risk-based breast cancer screening, as well as several European actions in prevention and precision medicine. Dr. Delaloge has authored more than 370 peer-reviewed international publications (Scopus H-index: 76) and is actively involved in editorial activities, professional guidelines, and medical education. She was appointed Knight of the French National Order of the Legion of Honour in 2019, Officer of the National Order of Merit in 2025, and received the Ruban Rose Research Grand Prize in 2024.

